Fitzbio Research HubEducational content only — not medical advice
Fitzbio
ENBM

Growth-hormone research

CJC-1295 with DAC

A long-acting GHRH analogue used in laboratory endocrine-signalling research.

18 connected records18 graded citations0 external identifiers

Research context

A long-acting GHRH analogue used in laboratory endocrine-signalling research.

Regulatory note: Verify local laws, product approval and professional guidance before any human use. This profile is not a recommendation for use.

Evidence map

Claims linked to original records.

Evidence levels describe study design. They do not by themselves establish safety or effectiveness.

Not yet classified

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

pubmed 2026
Not yet classified

&NA; · Springer Science and Business Media LLC

CJC 1131* [DAC: GLP-1] is effective in reducing glucose levels in patients with type 2 diabetes mellitus,

crossref 2004
Not yet classified

Marie Claire Van Hout, Evelyn Hearne · Substance Use & Misuse · 39 citations

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions

openalex 2016
Not yet classified

Sam L. Teichman, Ann C. Neale, Betty Lawrence, Catherine Gagnon, Jean‐Paul Castaigne, Lawrence A. Frohman · The Journal of Clinical Endocrinology & Metabolism · 45 citations

Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults

openalex 2006
Not yet classified

Mark Timms, Katherine E. Ganio, Grace Forbes, Simon R. Bailey, Rohan Steel · Drug Testing and Analysis · 4 citations

An immuno polymerase chain reaction screen for the detection of CJC‐1295 and other growth‐hormone‐releasing hormone analogs in equine plasma

openalex 2018
Not yet classified

Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz, Ewelina Szczepanek‐Parulska, Remigiusz Domin, Marek Ruchała · Frontiers in Endocrinology · 1 citations

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

openalex 2026
Not yet classified

Siham Memdouh, Ivana Gavrilović, Kelsey Ng, David Cowan, Vincenzo Abbate · Drug Testing and Analysis · 18 citations

Advances in the detection of growth hormone releasing hormone synthetic analogs

openalex 2021
Not yet classified

Carl Grünfeld, Argyris Dritselis, Peter N. Kirkpatrick · Nature Reviews Drug Discovery · 0 citations

Bodybuilding Peptides Cjc 1295 Dac Cjc-1295 Powder

openalex 2011
Not yet classified

Nicolas Fabresse, Laurie Gheddar, Pascal Kintz, A. Knapp, Islam Amine Larabi, Jean‐Claude Alvarez · Forensic Science International · 57 citations

Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders

openalex 2021
Not yet classified

Steven Janvier, Evelien De Sutter, Evelien Wynendaele, Bart M. J. De Spiegeleer, Céline Vanhee, Eric Deconinck · Talanta · 22 citations

Analysis of illegal peptide drugs via HILIC-DAD-MS

openalex 2017

Connected data hub

Records with source provenance.

Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.

Publication

1 records
pubmedAutomated import

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M

423951762026-09-27

Article

7 records
openalexAutomated import

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz, Ewelina Szczepanek‐Parulska, Remigiusz Domin, Marek Ruchała · Frontiers in Endocrinology · 1 citations

10.3389/fendo.2026.18224752026-06-18
openalexAutomated import

Advances in the detection of growth hormone releasing hormone synthetic analogs

Siham Memdouh, Ivana Gavrilović, Kelsey Ng, David Cowan, Vincenzo Abbate · Drug Testing and Analysis · 18 citations

10.1002/dta.31832021-10-20
openalexAutomated import

Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders

Nicolas Fabresse, Laurie Gheddar, Pascal Kintz, A. Knapp, Islam Amine Larabi, Jean‐Claude Alvarez · Forensic Science International · 57 citations

10.1016/j.forsciint.2021.1107712021-03-30
openalexAutomated import

An immuno polymerase chain reaction screen for the detection of CJC‐1295 and other growth‐hormone‐releasing hormone analogs in equine plasma

Mark Timms, Katherine E. Ganio, Grace Forbes, Simon R. Bailey, Rohan Steel · Drug Testing and Analysis · 4 citations

10.1002/dta.25542018-11-29
openalexAutomated import

Analysis of illegal peptide drugs via HILIC-DAD-MS

Steven Janvier, Evelien De Sutter, Evelien Wynendaele, Bart M. J. De Spiegeleer, Céline Vanhee, Eric Deconinck · Talanta · 22 citations

10.1016/j.talanta.2017.06.0342017-06-14
openalexAutomated import

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions

Marie Claire Van Hout, Evelyn Hearne · Substance Use & Misuse · 39 citations

10.3109/10826084.2015.10825952016-01-02
openalexAutomated import

Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults

Sam L. Teichman, Ann C. Neale, Betty Lawrence, Catherine Gagnon, Jean‐Paul Castaigne, Lawrence A. Frohman · The Journal of Clinical Endocrinology & Metabolism · 45 citations

10.1210/jc.2005-15362006-02-06

Scholarly Work

9 records
crossrefAutomated import

Acute Coronary Syndromes

· Elsevier BV

10.1016/j.cjco.2025.06.0112025-10-01
crossrefAutomated import

CWHHS Title Page

· Elsevier BV

10.1016/s2589-790x(25)00388-92025-06-01
crossrefAutomated import

Author Corrections

· Elsevier BV

10.1016/j.cjco.2025.03.0052025-05-01
crossrefAutomated import

Erratum

· Elsevier BV

10.1016/j.cjco.2021.08.0082021-10-01
crossrefAutomated import

Erratum

· Elsevier BV

10.1016/j.cjco.2021.02.0112021-06-01
crossrefAutomated import

Errata

· Elsevier BV

10.1016/j.cjco.2020.12.0142021-02-01
crossrefAutomated import

Errata

· Elsevier BV

10.1016/j.cjco.2020.12.0152021-02-01
crossrefAutomated import

Erratum

· Elsevier BV

10.1016/j.cjco.2019.11.0082020-01-01
crossrefAutomated import

CJC 1131* [DAC: GLP-1] is effective in reducing glucose levels in patients with type 2 diabetes mellitus,

&NA; · Springer Science and Business Media LLC

10.2165/00128413-200414340-000272004-04-01

Review

1 records
openalexAutomated import

Bodybuilding Peptides Cjc 1295 Dac Cjc-1295 Powder

Carl Grünfeld, Argyris Dritselis, Peter N. Kirkpatrick · Nature Reviews Drug Discovery · 0 citations

W31337247562011-02-01

Live discovery

Latest research signals

Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.

Recent PubMed records

Detection of CJC-1295 in Equine Plasma by ELISA.PMID 42876013 · 2026 Oct 14The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.PMID 42395176 · 2026

Registered clinical studies

Reviewed UniProt records

Responsible use of information

Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.